BioSpace News Archive

Exavir Therapeutics today announced that the company has received a $3M award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institute of Health (NIH), to support the development of XVIR-110.

Kinaxis® Inc., the leading supply chain management platform, was selected by F.I.S. - Fabbrica Italiana Sintetici S.p.A. to enable concurrent planning in its supply chain.

Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, announced an initial closing of its inaugural fund, Foundery I, LP, with total capital commitments and contributed assets as of the closing equal to $29.6 million.

Vincerx Pharma, Inc. today reported that it has received clearance for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VIP943.

Eli Lilly and Company (NYSE: LLY) today announced topline results from the LIBRETTO-531 study evaluating Retevmo versus physician’s choice of the multikinase inhibitors (MKIs) cabozantinib or vandetanib as an initial treatment for patients with advanced or metastatic rearranged during transfection (RET) -mutant medullary thyroid cancer (MTC).

Cabaletta Bio, Inc. today announced that it has entered into certain work orders relating to Good Manufacturing Practice (GMP) manufacturing under its existing master services agreement with WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO).

PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today that it has successfully completed the first commercial Aquablation® therapy procedures in Japan.

Longeveron Inc. announced that the subscription period for its previously announced rights offering has begun.

Reflect Scientific, Inc., a leading provider of advanced cryogenic cooling solutions, is pleased to announce the receipt of a substantial order worth $200,000 from a major Bio-Pharma customer for its state-of-the-art Blast Freezers.

Transnetyx, a global leader in outsourced genetic services, announced the acquisition of Laragen, a sequencing and genetic services company in Culver City, CA.